文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

三种不同的基于 archaeosome 的疫苗制剂所诱导的免疫应答的比较。

A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.

机构信息

Human Health Therapeutics, National Research Council Canada, Ottawa, ON K1A 0R6, Canada.

Nanotechnology Research Center, National Research Council Canada, Edmonton, AB T6G 2M9, Canada.

出版信息

Int J Pharm. 2019 Apr 20;561:187-196. doi: 10.1016/j.ijpharm.2019.02.041. Epub 2019 Mar 2.


DOI:10.1016/j.ijpharm.2019.02.041
PMID:30836154
Abstract

Archaeosomes are liposomes composed of natural or synthetic archaeal lipids that can be used as adjuvants to induce strong long-lasting humoral and cell-mediated immune responses against entrapped antigen. However, the entrapment efficiency of antigen within archaeosomes constituted using standard liposome forming methodology is often only 5-40%. In this study, we evaluated different formulation methods using a simple semi-synthetic archaeal lipid (SLA, sulfated lactosyl archaeol) and two different antigens, ovalbumin (OVA) and hepatitis B surface antigen (HBsAg). Antigen was entrapped within archaeosomes using the conventional thin film hydration-rehydration method with or without removal of non-entrapped antigen, or pre-formed empty archaeosomes were simply admixed with an antigen solution. Physicochemical characteristics were determined (size distribution, zeta potential, vesicle morphology and lamellarity), as well as location of antigen relative to bilayer using cryogenic transmission electron microscopy (TEM). We demonstrate that antigen (OVA or HBsAg) formulated with SLA lipid adjuvants using all the different methodologies resulted in a strong antigen-specific immune response. Nevertheless, the advantage of using a drug substance process that comprises of simply admixing antigen with pre-formed empty archaeosomes, represents a simple, efficient and antigenic dose-sparing formulation for adjuvanting and delivering vaccine antigens.

摘要

类病毒体是由天然或合成的古菌脂质组成的脂质体,可用作佐剂,以诱导针对包封抗原的强烈持久的体液和细胞介导的免疫应答。然而,使用标准脂质体制备方法制备的类病毒体对包封抗原的包封效率通常仅为 5-40%。在这项研究中,我们使用一种简单的半合成古菌脂质(SLA,硫酸化乳酰基古菌醇)和两种不同的抗原(卵清蛋白(OVA)和乙型肝炎表面抗原(HBsAg))评估了不同的配方方法。使用常规的薄膜水化-再水化方法,在有或没有去除未包封抗原的情况下,或预先形成的空类病毒体与抗原溶液简单混合,将抗原包封在类病毒体中。确定了物理化学特性(粒径分布、Zeta 电位、囊泡形态和层状结构),以及使用低温透射电子显微镜(TEM)确定抗原相对于双层的位置。我们证明,使用 SLA 脂质佐剂通过所有不同方法学制备的抗原(OVA 或 HBsAg)可引发强烈的抗原特异性免疫应答。然而,使用包含简单混合抗原与预先形成的空类病毒体的药物制剂工艺的优势在于,对于佐剂和递送疫苗抗原而言,这是一种简单、高效且节省抗原剂量的制剂。

相似文献

[1]
A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.

Int J Pharm. 2019-3-2

[2]
Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity.

Hum Vaccin Immunother. 2017-5-24

[3]
Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice.

PLoS One. 2018-12-4

[4]
In vitro evaluation of archaeosome vehicles for transdermal vaccine delivery.

J Liposome Res. 2017-9-26

[5]
Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations.

Hum Vaccin Immunother. 2020-9-1

[6]
Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants.

Hum Vaccin Immunother. 2018-1-30

[7]
Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum.

Infect Immun. 2000-1

[8]
Generation of a Liposomal Vaccine Adjuvant Based on Sulfated S-Lactosylarchaeol (SLA) Glycolipids.

Methods Mol Biol. 2022

[9]
Assessment of stability of sulphated lactosyl archaeol archaeosomes for use as a vaccine adjuvant.

J Liposome Res. 2021-9

[10]
Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.

Crit Rev Biotechnol. 1999

引用本文的文献

[1]
Modifying the glycosylation profile of SARS-CoV-2 spike-based subunit vaccines alters focusing of the humoral immune response in a mouse model.

Commun Med (Lond). 2025-4-11

[2]
Sulfated lactosyl archaeol (SLA) archaeosomes as a vaccine adjuvant.

Hum Vaccin Immunother. 2024-12-31

[3]
Liposomal delivery system/adjuvant for tuberculosis vaccine.

Immun Inflamm Dis. 2023-6

[4]
Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious.

Vaccines (Basel). 2023-5-31

[5]
Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern.

Front Immunol. 2023

[6]
Evaluation of Adjuvant Activity and Bio-Distribution of Archaeosomes Prepared Using Microfluidic Technology.

Pharmaceutics. 2022-10-26

[7]
Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern.

NPJ Vaccines. 2022-10-12

[8]
Vesicular and Planar Membranes of Archaea Lipids: Unusual Physical Properties and Biomedical Applications.

Int J Mol Sci. 2022-7-9

[9]
Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines.

Methods Mol Biol. 2022

[10]
Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant.

Sci Rep. 2021-11-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索